𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Bevacizumab Improves Pathological Response of Colorectal Cancer Liver Metastases Treated with XELOX/FOLFOX

✍ Scribed by Markus Klinger; Dietmar Tamandl; Sandra Eipeldauer; Stefan Hacker; Beata Herberger; Klaus Kaczirek; Marion Dorfmeister; Birgit Gruenberger; Thomas Gruenberger

Book ID
119986859
Publisher
Springer
Year
2010
Tongue
English
Weight
231 KB
Volume
17
Category
Article
ISSN
1068-9265

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Bevacizumab improves pathologic response
Bevacizumab improves pathologic response and protects against hepatic injury in patients treated with oxaliplatin-based chemotherapy for colorectal liver metastases
✍ Dario Ribero; Huamin Wang; Matteo Donadon; Daria Zorzi; Melanie B. Thomas; Cathy πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 271 KB

## Abstract ## BACKGROUND. The current study evaluated the effect of bevacizumab added to fluoropyrimidine‐plus‐oxaliplatin (5FU/OX) chemotherapy for colorectal liver metastases (CLM) on the pathologic response and nontumorous liver histology. ## METHODS. A total of 105 consecutive patients trea